Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

Share Price is delayed by 15 minutes
Get Live Data
44.50    -0.50 (-1.11%)
Bid:
44.00
Ask:
45.00
Spread: 1.00 (2.273%)
Market Cap: £85.38m
IOF Live PriceLast checked at - London Stock Exchange

Intraday Iofina Share Chart

Q4 2025 Corporate Update

13 Jan 2026 07:00

RNS Number : 5982O
Iofina PLC
13 January 2026
 

 

 

 

 

 

 

13 January 2026

 

Iofina plc

("Iofina", the "Company" or the "Group")

(AIM: IOF)

 

Q4 2025 Corporate UpdateAnother Record Year of Iodine Production

FY 2025 Revenue and EBITDA expected to Exceed Market Expectations1

 

Iofina plc, specialists in the exploration and production of iodine and manufacturers of specialty chemical products, today provides a market update regarding its activities during Q4 2025 (the "Period") and for the full year ended 31 December 2025.

 

In the Period, Iofina Resources produced 221.8 metric tonnes ("MT") of crystalline iodine from its eight IOsorb® plants in Central and Northwest Oklahoma (Q4 2024: 194.1 MT). Total crystalline iodine production during the second half of 2025 reached a record 437.6 MT (H2 2024: 358.0 MT), achieving the upper end of the Company's stated production guidance of 400-440 MT. Total crystalline iodine production for 2025 was a record 743.2 MT, up 17.2% from FY24 (FY24: 634.1 MT).

 

As a result of achieving the upper end of its production forecast along with a strong sales cycle in the second half of 2025, Iofina expects to exceed market expectations for revenue and EBITDA.1 Revenues for 2025 are projected to surpass $65m, and EBITDA for 2025 is expected to be greater than $11m. Additionally, the Company's net cash as at 31 December 2025 was $5.2m (FY24: $2.9m).

 

Regarding its growth projects, the Company continues to make progress on its next IOsorb® plant in the Permian Basin. The new plant is expected to process c.50,000 barrels of water, approximately twice the volume of the maximum brine throughput capacity of the existing Oklahoma IOsorb® plants, giving an annualised production target of 170-220MT. On current timelines, the operations team expects the new plant to be switched on in H2 2026.

 

The Company continues to advance its broader plant development pipeline and remains focused on delivering further production growth. The Company expects to produce between 325-355 MT of crystalline iodine in H1 2026 (H1 2025: 305.5MT). As previously communicated, the Company's iodine production is always second-half weighted due to the impact of winter conditions on the oil field, coupled with lower brine temperatures.

 

The spot iodine price was consistently above $70/kg throughout 2025, and the Company expects these market conditions to continue as we enter 2026 due to the continued robust global demand for iodine.

 

President and CEO, Dr. Tom Becker, commented:

 

"Iofina delivered another record year of production, reflecting the strength and consistency of our operations across all plants. The momentum in product sales experienced in H1 2025 continued throughout the second half of 2025. As a result, we expect full-year revenue and EBITDA to exceed current market expectations.

 

"Looking ahead, the Board is excited by the outlook for Iofina. We believe that the business is in a very strong position against a backdrop of increasing demand for its iodine products and our ongoing programme to continue expanding our iodine production capacity. Construction of our largest plant to date is underway in the Permian Basin, and we continue to execute our growth strategy, which we believe will result in another strong year in 2026 for Iofina. We look forward to providing further updates on the progress of the new plant and across the wider business in due course."

 

This announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018.

 

1For the purpose of this announcement, the Company believes market expectations for 2025 to be revenues of $62.8 million and EBITDA $10.5 million.

 

Enquiries:

 

Iofina plc

Dr. Tom Becker

CEO & President

Tel: +44 (0)20 3006 3135

 

Nomad & Broker:

Canaccord Genuity Limited

Henry Fitzgerald-O'Connor/Harry Rees

Tel: +44 (0)20 7523 8000

 

Financial PR and Media Contact:

Yellow Jersey PR Limited

Charles Goodwin/Shivantha Thambirajah/Maya Brookes

Tel: +44 (0)7747 788 221/+44 (0)7983 521 488

 

About Iofina:

Iofina plc (AIM: IOF) is a vertically integrated company that specialises in the production of Iodine and the manufacturing of specialty chemical products. Iofina is the second largest producer of iodine in North America and operates the manufacturing entities Iofina Resources and Iofina Chemical.

LEI: 213800QDMFYVRJYYTQ84

ISIN: GB00B2QL5C79

 

Iofina Resources

Iofina Resources develops, builds, owns, and operates iodine extraction plants using Iofina's WET® IOsorb® technology. Iofina operates eight IOsorb® plants in Oklahoma and consistently uses technology and innovation to improve and expand its operations.

 

Iofina Chemical

Iofina Chemical has manufactured high-quality halogen speciality chemicals derived from raw iodine, as well as non-iodine-based products. Iofina Chemical celebrated its 40th anniversary in 2023 as a preeminent halogen-based specialty chemicals company.

 

www.iofina.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDBLLLFQFLZBBX
Date   Source Headline
9th Jun 202612:30 pmRNSResult of AGM
5th Jun 20267:00 amRNSAgreement Signed for Additional Brine Water Supply
5th May 20267:00 amRNSNotice of AGM
30th Apr 20264:45 pmRNSHolding(s) in Company
30th Apr 202611:30 amRNSHolding(s) in Company
30th Apr 20267:00 amRNSFinal Results
16th Apr 20261:40 pmRNSHolding(s) in Company
15th Apr 20267:00 amRNSQ1 2026 Corporate Update
20th Mar 202612:25 pmRNSHolding(s) in Company
13th Jan 20267:00 amRNSQ4 2025 Corporate Update
6th Jan 20267:00 amRNSHolding(s) in Company
12th Dec 20257:00 amRNSDirectorate change
5th Dec 20257:00 amRNSAgreement with Western Midstream
12th Nov 20258:15 amRNSHolding(s) in Company
16th Oct 20257:00 amRNSQ3 2025 Update
3rd Oct 20253:32 pmRNSHolding(s) in Company
18th Sep 20257:00 amRNSInterim Results
4th Sep 20257:00 amRNSBusiness Update
17th Jul 20257:00 amRNSH1 2025 Update
9th Jul 20257:00 amRNSCapital Reduction
9th Jun 20255:00 pmRNSResult of AGM
14th May 20257:00 amRNSNotice of AGM and Proposed Capital Reduction
12th May 20257:00 amRNS-RInvestor Presentation
12th May 20257:00 amRNSFinal Results
25th Apr 20253:45 pmRNSHolding(s) in Company
17th Apr 20257:00 amRNSQ1 2025 Update
23rd Jan 20257:00 amRNSQ4 2024 Update
18th Dec 20244:45 pmRNSHolding(s) in Company
21st Oct 20247:00 amRNSHolding(s) in Company
18th Oct 20247:00 amRNSQ3 2024 Update
27th Sep 20247:00 amRNSIO#11 Update
20th Sep 20247:00 amRNSInterim Results
13th Sep 20247:00 amRNSIO#10 Iodine Plant Commissioned
16th Jul 20247:00 amRNSH1 Update
27th Jun 202411:04 amRNSHolding(s) in Company
25th Jun 20247:00 amRNSHolding(s) in Company
13th Jun 20241:00 pmRNSResult of AGM
29th May 20244:50 pmRNSLaunch of new website
15th May 20247:00 amRNSNotice of AGM and Resignation of Director
2nd May 20247:00 amRNSFinal Results
16th Apr 20247:00 amRNSQ1 2024 Corporate Update
17th Jan 20247:00 amRNSHolding(s) in Company
15th Jan 20247:00 amRNSQ4 2023 Corporate Update
30th Nov 20237:00 amRNSIO#9 Update
20th Oct 20237:00 amRNSSigned Agreement for IO#10 and Q3 2023 Update
11th Sep 20237:00 amRNSInterim Results
25th Aug 20235:00 pmRNSHolding(s) in Company
24th Jul 20235:00 pmRNSHolding(s) in Company
20th Jul 20237:00 amRNSH1 Update and Updated Loan Facilities
14th Jun 20232:00 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.